Skip to main content
. 2017 Nov 15;9(11):5063–5073.

Table 2.

Echocardiography and CMR data

Control HCM
n 20 50
Echocardiography
    Left atrial volume (ml/BSA) 27.6±8.9 45.3±15.5***
    E/A ratio 1.38±0.36 1.35±0.56
    Deceleration time (ms) 182.1±27.0 213.2±57.3*
    Septal e’ (cm/s) 10.6±2.9 6.1±1.6***
    Lateral e’ (cm/s) 13.7±3.5 8.3±2.8***
    Mean e’ (cm/s) 12.1±3.0 7.2±2.0***
    Septal E/e’ 8.5±2.6 13.9±5.5***
    Lateral E/e’ 6.3±1.9 10.7±5.0***
    Mean E/e’ 7.8±2.6 12.2±4.8***
    Resting LVOT gradient (mmHg) 5.2±1.2 38.5±45.1**
CMR
    Septal thickness (mm) 8.3±1.8 19.2±4.8***
    Lateral wall thickness (mm) 7.9±1.5 8.6±1.8
    Septal/lateral wall thickness 1.1±0.1 2.3±0.6***
    LV mass (g) 113.1±20.6 171.1±61.6***
    LV mass index (g/BSA) 57.5±8.0 86.2±28.0***
    LV ejection fraction (%) 60.9±5.8 69.5±7.3**
    LVEDV (mL) 180.4±29.1 160.3±38.6
    LVEDV indexed (mL/BSA) 91.9±11.5 78.0±21.8
    LVESV (mL) 72.4±22.6 48.3±20.4***
    LVSV (mL) 108.0±7.8 106.5±35.2
    Presence of LGE (%) NA 86%
    Quantity of LGE (% of LV) mass NA 5.1±6.7
    T1 times (ms), excluding LGE 578.4±45.4 497.5±79.2*
    T1 times (ms), including LGE 578.4±45.4 481.2±83.8**
    T1 times (ms, corrected values) 566.3±49.6 478.6±80.9**
    Blood T1 times (ms) 303.1±13.7 334.6±31.5

Data are expressed as mean ± SD. CMR: Cardiac magnetic resonance; LVOT: Left ventricular outflow tract; LV: Left ventricular; LVEDV: Left ventricular end-diastolic volume; LVESV: Left ventricular end-systolic volume; LVSV: Left ventricular stroke volume; LGE: Late gadolinium enhancement; BSA: Body surface area; T1 times (corrected values): T1 times were normalized to a matched state (time post-contrast administration =20 minutes, eGFR =90 mL/min/1.73 m2) to account for the potential effects of glomerular filtration rate, time delay post-contrast administration, and contrast agent relaxivity on gadolinium pharmacokinetics.

*

P<0.05, vs. controls;

**

P<0.01, vs. controls;

***

P<0.001, vs. controls.